A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
Clinical trial NCT03589326 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03589326
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-04
- Primary completion
- 2022-08-12
- Enrollment
- 245
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.